# Antibiotic Prophylaxis for Bladder Botox

> **NCT04444440** · PHASE4 · RECRUITING · sponsor: **University of Alberta** · enrollment: 202 (estimated)

## Conditions studied

- Idiopathic Overactive Bladder
- Postoperative Urinary Tract Infection

## Interventions

- **DRUG:** Ciprofloxacin
- **OTHER:** Placebo Pill

## Key facts

- **NCT ID:** NCT04444440
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-28
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 202 (ESTIMATED)
- **Last updated:** 2025-09-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04444440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04444440, "Antibiotic Prophylaxis for Bladder Botox". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04444440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*